[{"data":1,"prerenderedAt":63},["ShallowReactive",2],{"q-nurse-106-2-medical-surgical-038":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":33,"lastmod":62},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"explanationDeep":22,"topics":23,"freq":26},"nurse-106-2-內外科護理學-038","nurse-106-2-medical-surgical-038",106,2,38,"下列何種疾病有 90%的病人體內可發現費城染色體（Philadelphia chromosome）？",{"A":14,"B":15,"C":16,"D":17},"急性骨髓性白血病","慢性骨髓性白血病","急性淋巴性白血病","慢性淋巴性白血病","B",null,[],"本題考點是費城染色體(Philadelphia chromosome)的疾病關聯。費城染色體為第9與第22對染色體易位t(9;22)產生BCR-ABL融合基因,是慢性骨髓性白血病(CML)的特徵性標記,約90%以上CML病人可測得,故選(B)。(A)急性骨髓性白血病、(C)急性淋巴性白血病、(D)慢性淋巴性白血病雖偶見其他染色體異常,但以費城染色體高度陽性為診斷標記者是CML,故正確對應為慢性骨髓性白血病。","BCR-ABL融合基因產生持續活化的酪胺酸激酶,驅動骨髓細胞增生。標靶藥物imatinib(基利克)等酪胺酸激酶抑制劑正是針對此機轉,使CML預後大幅改善,為標靶治療的經典範例。少數ALL(Ph陽性ALL)亦帶費城染色體且預後較差,但『90%高陽性』對應者為CML。",[24,27,29,31],{"term":25,"count":26},"費城染色體",3,{"term":15,"count":28},1,{"term":30,"count":28},"BCR-ABL",{"term":32,"count":28},"酪胺酸激酶抑制劑",[34,38,43,47,52,57],{"webId":35,"stem":36,"number":37,"year":9,"session":10},"nurse-106-2-medical-surgical-039","下列那種檢查是協助確定癌症診斷最有效的方法？",39,{"webId":39,"stem":40,"number":41,"year":42,"session":28},"nurse-107-1-medical-surgical-055","有關肺氣腫之敘述，下列何者錯誤？",55,107,{"webId":44,"stem":45,"number":46,"year":42,"session":10},"nurse-107-2-medical-surgical-069","有關皮下注射胰島素吸收速率之比較，下列何者正確？",69,{"webId":48,"stem":49,"number":50,"year":51,"session":28},"nurse-109-1-medical-surgical-027","有關心臟復健（Cardiac Rehabilitation, CR）運動原則之敘述，下列何者錯誤？",27,109,{"webId":53,"stem":54,"number":55,"year":56,"session":28},"nurse-110-1-medical-surgical-071","有關糖化血色素（HbA1c）檢查之敘述，下列何者正確？",71,110,{"webId":58,"stem":59,"number":60,"year":61,"session":10},"nurse-111-2-medical-surgical-025","有關扁桃腺炎的處置，下列何者錯誤？",25,111,"2026-09-04",1788510698594]